J. De Keyser

N M Maurits, N. Maurits, J. De Keyser, 2003, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

Thromboelastography in patients with cerebral venous thrombosis.

J. van der Meer, J. De Keyser, G. Luijckx, 2009, Thrombosis research.

Two Time Point MS Lesion Segmentation in Brain MRI: An Expectation-Maximization Framework

Michael H. Barnett, Sabine Van Huffel, Frederik Maes, 2016, Front. Neurosci..

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations

J. De Keyser, G. Luijckx, P. Vroomen, 2007, Stroke.

J. De Keyser, G. Vauquelin, G. Ebinger, 1990, Annals of neurology.

D1-dopamine receptor abnormality in frontal cortex points to a functional alteration of cortical cell membranes in Alzheimer's disease.

J. De Keyser, G. Vauquelin, G. Ebinger, 1990, Archives of neurology.

Pitfalls in the diagnosis of reversible cerebral vasoconstriction syndrome and primary angiitis of the central nervous system

J. De Keyser, G. Luijckx, P. Vroomen, 2007, European journal of neurology.

Autologous mesenchymal stem cell transplantation in stroke patients

J. De Keyser, 2005, Annals of neurology.

Post-stroke infections associated with spleen volume reduction: A pilot study

J. De Keyser, K. Nieboer, A. Vanbinst, 2020, PloS one.

Are astrocytes central players in the pathophysiology of multiple sclerosis?

E. Frohman, J. De Keyser, E. Zeinstra, 2003, Archives of neurology.

Management of acute ischaemic stroke.

J. De Keyser, J. van der Naalt, J. Elting, 1999, Acta clinica Belgica.

Acute Stroke Management in Patients Taking Dabigatran

J. De Keyser, M. Moens, G. Luijckx, 2012, CNS neuroscience & therapeutics.

Curlometer Technique and Applications

J. De Keyser, J. Eastwood, Z. Rong, 2021, Journal of Geophysical Research: Space Physics.

High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.

J. De Keyser, G. Vauquelin, A. Convents, 1989, Biochemical pharmacology.

Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.

J. De Keyser, E. Schrijvers, G. Luijckx, 2007, Age and ageing.

European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre‐hospital management of stroke

Ana Catarina Fonseca, G. Ford, J. Kõrv, 2018, European journal of neurology.

Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis

J. De Keyser, G. Luijckx, M. Koch, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies.

J. De Keyser, G. Luijckx, R. Brouns, 2011, Acta neurologica Belgica.

Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic Stroke

J. De Keyser, R. Gens, S. De Raedt, 2021, Frontiers in Neurology.

Does smoking influence outcome after intravenous thrombolysis for acute ischaemic stroke?

J. De Keyser, G. Luijckx, P. Vroomen, 2009, European journal of neurology.

White-Matter Astrocytes, Axonal Energy Metabolism, and Axonal Degeneration in Multiple Sclerosis

M. Cambron, J. De Keyser, J. Debruyne, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Insulin-Like Growth Factor I: A Potential Neuroprotective Compound for the Treatment of Acute Ischemic Stroke?

Y. Michotte, J. De Keyser, R. Kooijman, 2009, Stroke.

Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide

Y. Michotte, J. De Keyser, R. Kooijman, 2012, Journal of Neuroinflammation.

Exaggerated Postural Blood Pressure Rise Is Related to a Favorable Outcome in Patients With Acute Ischemic Stroke

M. Aries, J. De Keyser, J. Elting, 2012, Stroke.

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

Vivian Gu, Salim Yusuf, Gregory W Albers, 2008, The New England journal of medicine.

The insulin-like growth factor system in multiple sclerosis.

N. Wilczak, J. De Keyser, D. Chesik, 2007, International review of neurobiology.

Prior Anticoagulant Therapy, Subtherapeutic International Normalized Ratio and Thrombolytic Therapy in Acute Ischemic Stroke

B. Kremer, J. De Keyser, G. Luijckx, 2011, International journal of stroke : official journal of the International Stroke Society.

RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions

K. Kersse, P. Vandenabeele, J. De Keyser, 2014, Cell Death and Disease.

A randomized crossover study of bee sting therapy for multiple sclerosis

M. van Buchem, F. Admiraal-Behloul, J. De Keyser, 2005, Neurology.

Intravenous Tissue Plasminogen Activator in Patients With Stroke Increases the Bioavailability of Insulin-Like Growth Factor-1

N. Wilczak, J. De Keyser, D. Chesik, 2006, Stroke.

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

M. Versavel, H. Diener, M. Hommel, 2005, Cerebrovascular Diseases.

Search for morbillivirus proteins in multiple sclerosis brain tissue

N. Wilczak, J. De Keyser, R. V. Van BInnendijk, 2004, Neuroreport.

Insulin-like growth factor system in amyotrophic lateral sclerosis.

N. Wilczak, J. De Keyser, 2005, Endocrine development.

Intracranial Hypertension Induced by Rofecoxib

J. De Keyser, G. Luijckx, J. van der Naalt, 2005, Headache.

The Effect of Fluoxetine on Progression in Progressive Multiple Sclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial

M. van Buchem, J. van der Grond, J. De Keyser, 2013, ISRN neurology.

Successful repetitive intravenous thrombolysis in a patient with recurrent brainstem infarctions due to megadolichobasilar ectasia.

M. Cambron, J. De Keyser, R. Brouns, 2013, JAMA neurology.

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran

J. De Keyser, R. Brouns, A. De Smedt, 2010, Cerebrovascular Diseases.

Modifiable factors influencing relapses and disability in multiple sclerosis

G. Nagels, J. De Keyser, M. D'hooghe, 2010, Multiple sclerosis.

Insulin‐like growth factor‐binding protein 6 inhibits survival and differentiation of rat oligodendrocyte precursor cells

J. De Keyser, N. Kühl, D. Hoekstra, 2003, Glia.

Insulin‐like growth factor (IGF)‐I binding to a cell membrane associated IGF binding protein‐3 acid‐labile subunit complex in human anterior pituitary gland

N. Wilczak, J. De Keyser, D. Chesik, 2002, Journal of neurochemistry.

Respiratory dyskinesia in Parkinson's disease

J. De Keyser, W. Vincken, 1986, Neurology.

Astrocytic β2 Adrenergic Receptor Gene Deletion Affects Memory in Aged Mice

J. De Keyser, L. Ris, A. Massie, 2016, PloS one.

IGF-1 regulates cAMP levels in astrocytes through a β2-adrenergic receptor-dependant mechanism

N. Wilczak, J. De Keyser, D. Chesik, 2008, International journal of medical sciences.

Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis

J. De Keyser, J. Mostert, M. Koch, 2008, Multiple sclerosis.

Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course

J. De Keyser, A. Teelken, A. Arutjunyan, 2004, Neurology.

Insulin‐like growth factor binding proteins‐1 and ‐2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro

J. De Keyser, N. Kühl, D. Hoekstra, 2002, Journal of neuroscience research.

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Apixaban

M. Cambron, J. De Keyser, M. Moens, 2014, International journal of stroke : official journal of the International Stroke Society.

Thrombolysis for acute ischemic stroke.

J. De Keyser, G. Luijckx, M. Uyttenboogaart, 2009, Current topics in medicinal chemistry.

Flunitrazepam intoxication simulating a structural brainstem lesion.

J. De Keyser, D. Deleu, 1987, Journal of neurology, neurosurgery, and psychiatry.

Management of acute ischaemic stroke.

J. De Keyser, J. van der Naalt, J. Elting, 1999, Acta clinica Belgica.

Regional distribution of alpha 2A- and alpha 2B-adrenoceptor subtypes in postmortem human brain.

J. De Keyser, G. Vauquelin, I. Van Liefde, 1992, Journal of neurochemistry.

Intra-arterial blood pressure reading in intensive care unit patients in the lateral position.

M. Aries, J. Zijlstra, A. Aslan, 2012, Journal of clinical nursing.

Worsening of symptoms of multiple sclerosis associated with carbamazepine

J. De Keyser, G. Ramsaransing, C. Zwanikken, 2000, BMJ : British Medical Journal.

Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years

J. van der Meer, J. De Keyser, G. Luijckx, 2009, Thrombosis and Haemostasis.

Insulin‐like growth factor binding protein‐1 activates integrin‐mediated intracellular signaling and migration in oligodendrocytes

Reinier Bron, J. De Keyser, D. Chesik, 2010, Journal of neurochemistry.

Enhanced proliferation of astrocytes from β2‐adrenergic receptor knockout mice is influenced by the IGF system

N. Wilczak, J. De Keyser, D. Chesik, 2006, Journal of neurochemistry.

Insulin‐like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells

N. Wilczak, J. De Keyser, D. Chesik, 2006, The European journal of neuroscience.

Enhanced production and proteolytic degradation of insulin‐like growth factor binding protein‐2 in proliferating rat astrocytes

N. Wilczak, J. De Keyser, D. Chesik, 2004, Journal of neuroscience research.

Progressive paraparesis due to thoracic extramedullary hematopoiesis in myelofibrosis. Case report.

J. De Keyser, C. Bourgain, G. Ebinger, 1993, Journal of neurosurgery.

Self‐reported levels of education and disability progression in multiple sclerosis

G. Nagels, P. Haentjens, J. De Keyser, 2016, Acta neurologica Scandinavica.

The European Stroke Organisation Guidelines: a standard operating procedure

H. Diener, D. Leys, J. Ferro, 2015, International journal of stroke : official journal of the International Stroke Society.

Headache associated with cough: a review

J. De Keyser, W. de Hertogh, J. Versijpt, 2013, The Journal of Headache and Pain.

Intracranial artery dissection

J. De Keyser, G. Luijckx, R. Brouns, 2014, European journal of neurology.

The Premenstrual Period and Exacerbations in Multiple Sclerosis

J. De Keyser, A. Zorgdrager, 2002, European Neurology.

Premenstrual exacerbations of multiple sclerosis

J. De Keyser, A. Zorgdrager, 1998, Journal of neurology, neurosurgery, and psychiatry.

Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease.

C. Baeken, J. De Keyser, A. Flamez, 2016, Parkinsonism & related disorders.

Identification of D1-like dopamine receptors on human blood platelets.

J. De Keyser, G. Vauquelin, A. Convents, 1988, Life sciences.

An often unrecognized cause of thunderclap headache: reversible cerebral vasoconstriction syndrome

J. De Keyser, G. Luijckx, P. Vroomen, 2008, The Journal of Headache and Pain.

Simvastatin inhibits interferon-γ-induced MHC class II up-regulation in cultured astrocytes

N. Wilczak, J. De Keyser, D. Chesik, 2006, Journal of Neuroinflammation.

Antipyretics in acute ischaemic stroke.

J. De Keyser, 1998, Lancet.

Cooling garment treatment in MS: Clinical improvement and decrease in leukocyte NO production

J. De Keyser, E. Beenakker, A. Teelken, 2001, Neurology.

Uric acid in multiple sclerosis

J. De Keyser, M. Koch, 2006, Neurological research.

Autoimmunity in multiple sclerosis.

J. De Keyser, 1988, Neurology.

Rapidly Progressive Cerebellar Hemiataxia with High Levels of GAD65 Reactive Antibodies

L. Seynaeve, J. De Keyser, A. Flamez, 2017, Movement disorders clinical practice.

[3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.

J. De Keyser, G. Vauquelin, A. Convents, 1989, European journal of pharmacology.

Reduced information processing speed as primum movens for cognitive decline in MS

G. Nagels, J. De Keyser, J. Van Schependom, 2015, Multiple sclerosis.

Seizures in multiple sclerosis

J. De Keyser, M. Koch, M. Uyttenboogaart, 2008, Epilepsia.

(www.interscience.wiley.com). DOI: 10.1002/rmv.526 Involvement of morbilliviruses in the pathogenesis of demyelinating disease

N. Wilczak, J. De Keyser, D. Chesik, 2022 .

The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results

J. De Keyser, P. Van Schuerbeek, M. D’haeseleer, 2020, Frontiers in Neurology.

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1

M. Cambron, J. De Keyser, Y. Fierens, 2013, Proceedings of the National Academy of Sciences.

Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis

Ilja M. Nolte, P. Terpstra, R. Hofstra, 2001, Neurogenetics.

Risks of multiple sclerosis in relatives of patients in Flanders, Belgium.

A. Sadovnick, R. Loos, R. Vlietinck, 1997, Journal of neurology, neurosurgery, and psychiatry.

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes

J. Raes, G. Nagels, J. De Keyser, 2020, Annals of clinical and translational neurology.

Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis

G. Nagels, M. Bjerke, Y. Gidron, 2019, Journal of clinical medicine.

Absence of system xc− on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis

J. De Keyser, P. Maher, P. Albrecht, 2017, Journal of Neuroinflammation.

T2 lesions and rate of progression of disability in multiple sclerosis

J. De Keyser, J. Mostert, J. D. de Groot, 2010, European journal of neurology.

Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled Multiple Sclerosis patients

J. De Keyser, K. Wynia, B. Middel, 2010, BMC health services research.

Adding a subjective dimension to an ICF-based disability measure for people with multiple sclerosis: development and use of a measure for perception of disabilities

H. de Ruiter, J. De Keyser, K. Wynia, 2009, Disability and rehabilitation.

The impact of disabilities on quality of life in people with multiple sclerosis

J. De Keyser, K. Wynia, S. Reijneveld, 2008, Multiple sclerosis.

Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients

J. Hoogduin, J. De Keyser, Y. Blaauw, 2008, European Radiology.

The Multiple Sclerosis Impact Profile (MSIP). Development and testing psychometric properties of an ICF-based health measure

H. de Ruiter, J. De Keyser, K. Wynia, 2008, Disability and rehabilitation.

Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosis

J. De Keyser, J. Mostert, J. D. de Groot, 2007, European journal of neurology.

Plasma lipid peroxidation and progression of disability in multiple sclerosis

J. De Keyser, J. Mostert, M. Koch, 2007, European journal of neurology.

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.

M Filippi, S G Waxman, M. Filippi, 2006, Archives of neurology.

Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis.

N. Wilczak, J. De Keyser, D. Chesik, 2007, Cytokine & growth factor reviews.

Meningoencephaloradiculitis following infection with tick borne encephalitis virus: case report and review of the literature

J. De Keyser, A. Flamez, R. Mertens, 2018, Acta Neurologica Belgica.

Pharmacologic treatment of depression in multiple sclerosis.

J. De Keyser, J. Mostert, M. Koch, 2011, The Cochrane database of systematic reviews.

Low leucocyte myeloperoxidase activity in patients with multiple sclerosis

J. De Keyser, A. Teelken, G. Ramsaransing, 2003, Journal of neurology, neurosurgery, and psychiatry.

Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis.

R. Benedict, G. Nagels, J. De Keyser, 2019, Multiple sclerosis and related disorders.

Immune Players in the CNS: The Astrocyte

J. De Keyser, A. Massie, C. Jensen, 2013, Journal of Neuroimmune Pharmacology.

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis

J. Raes, G. Falony, G. Nagels, 2023, Gut microbes.

Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis

J. De Keyser, M. D'hooghe, T. D’Hooghe, 2013, Gynecologic and Obstetric Investigation.

Delayed akinetic catatonic mutism following methadone overdose.

A. Michotte, J. De Keyser, A. Flamez, 2010, Neurotoxicology.

Coma as presenting manifestation of Wernicke's encephalopathy.

J. De Keyser, D. Deleu, G. Ebinger, 1985, The Journal of emergency medicine.

Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.

H. Diener, W. Hacke, M. Hennerici, 1996, Stroke.

High natural killer cell number might identify stroke patients at risk of developing infections

D. Coomans, J. De Keyser, R. Buyl, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Insulin‐like growth factor‐I receptors in human brain and pituitary gland: An autoradiographic study

N. Wilczak, J. De Keyser, G. Vauquelin, 1994, Synapse.

Reduced Creatine Kinase B Activity in Multiple Sclerosis Normal Appearing White Matter

J. Hoogduin, N. Wilczak, J. De Keyser, 2010, PloS one.

Cerebral Hypoperfusion: A New Pathophysiologic Concept in Multiple Sclerosis?

G. Nagels, J. De Keyser, M. D'hooghe, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Therapeutic Potential of Fluoxetine in Neurological Disorders

J. De Keyser, M. Heerings, J. Mostert, 2008, CNS neuroscience & therapeutics.

Perfusion computed tomography in the acute phase of mild head injury: Regional dysfunction and prognostic value

M. Oudkerk, J. De Keyser, J. van der Naalt, 2009, Annals of neurology.

Admitting Acute Ischemic Stroke Patients to a Stroke Care Monitoring Unit Versus a Conventional Stroke Unit: A Randomized Pilot Study

N. Maurits, J. De Keyser, J. Elting, 2003, Stroke.

Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance

J. De Keyser, J. Mostert, M. Koch, 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial

Guy Nagels, Melissa Cambron, G. Nagels, 2019, Multiple sclerosis.

Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study

M. van Buchem, F. Admiraal-Behloul, J. Hoogduin, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

J. De Keyser, J. Mostert, M. Koch, 2006, Neurology.

Prehospital Stroke Care: Limitations of Current Interventions and Focus on New Developments

Ives Hubloue, J. De Keyser, R. Brouns, 2014, Cerebrovascular Diseases.

Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis

G. Nagels, P. Haentjens, J. De Keyser, 2012, European journal of neurology.

Is positron emission tomography useful in stroke?

J. De Keyser, J. De Reuck, D. Leys, 1997, Acta neurologica Belgica.

Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis

J. De Keyser, D. Heersema, G. Ramsaransing, 2005, European journal of neurology.

Feasibility, Reliability and Predictive Value Of In-Ambulance Heart Rate Variability Registration

G. Nagels, J. De Keyser, R. Brouns, 2016, PloS one.

Acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis: a multisystem granulomatous disease.

W. D. den Dunnen, J. De Keyser, E. Timmerman, 2006, Archives of ophthalmology.

Multiparity in women with multiple sclerosis causes less long-term disability: Yes

J. De Keyser, M. D'hooghe, 2014, Multiple sclerosis.

Parity and secondary progression in multiple sclerosis

J. De Keyser, M. Koch, D. Heersema, 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

Plasma S100beta and NSE levels and progression in multiple sclerosis.

J. De Keyser, J. Mostert, M. Koch, 2007, Journal of the neurological sciences.

Television induced seizures in alcoholics.

A. Michotte, J. De Keyser, G. Ebinger, 1984, British medical journal.

Cigarette smoking and progression in multiple sclerosis

J. De Keyser, M. Koch, M. Uyttenboogaart, 2007, Neurology.

Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis

G. Nagels, P. Haentjens, J. De Keyser, 2012, Multiple sclerosis.

Heart Rate Variability and Baroreceptor Sensitivity in Acute Stroke: A Systematic Review

Guy Nagels, G. Nagels, J. De Keyser, 2015, International journal of stroke : official journal of the International Stroke Society.

Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors

N. Wilczak, J. De Keyser, R. Leta, 1999, Neurology.

Fatigue, depression and progression in multiple sclerosis

J. De Keyser, M. Heerings, M. Koch, 2008, Multiple sclerosis.

Long-term sequelae after cerebral venous thrombosis in functionally independent patients.

J. van der Meer, J. De Keyser, G. Luijckx, 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review

N. Maurits, J. De Keyser, J De Keyser, 2001, Multiple sclerosis.

The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.

J. De Keyser, G. Luijckx, P. Kamphuisen, 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

J. De Keyser, G. Luijckx, P. Vroomen, 2008, Archives of neurology.

Insulin-Like Growth Factor I Serum Levels Influence Ischemic Stroke Outcome

N. Wilczak, J. De Keyser, M. Moens, 2011, Stroke.

Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke.

J. De Keyser, G. Luijckx, P. Vroomen, 2007, Brain : a journal of neurology.

Fatigue, depression and disability accumulation in multiple sclerosis: a cross‐sectional study

J. De Keyser, J. Mostert, M. Koch, 2009, European journal of neurology.

Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study

J. De Keyser, G. S. Ramsaransing, Sanne A Mellema, 2009, Nutrition journal.

Optimizing Cutoff Scores for the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials

Maarten Uyttenboogaart, Gert-Jan Luijckx, J. De Keyser, 2005, Stroke.

Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes?

J. De Keyser, G. Luijckx, R. Brouns, 2016, BMC Neurology.

Neuroprotection in acute ischemic stroke.

J. De Keyser, G. Luijckx, J. Elting, 2005, Acta neurologica Belgica.

Statin Use and Functional Outcome after Tissue Plasminogen Activator Treatment in Acute Ischaemic Stroke

J. De Keyser, G. Luijckx, M. Uyttenboogaart, 2010, Cerebrovascular Diseases.

The European Stroke Scale

H. Feys, W. D. De Weerdt, R. Palm, 1994, Stroke.

Subtypes and localization of dopamine receptors in human brain.

J. De Keyser, 1993, Neurochemistry International.

PreSSUB II: The prehospital stroke study at the Universitair Ziekenhuis Brussel II

A. Dupont, K. Putman, L. de Wit, 2015, Journal of translational internal medicine.

Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial

W. van Hecke, G. Nagels, M. Cambron, 2014, Trials.

Factors associated with the risk of secondary progression in multiple sclerosis

J. De Keyser, M. Koch, M. Uyttenboogaart, 2008, Multiple sclerosis.

The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis

G. Nagels, J. De Keyser, J. Van Schependom, 2014, European journal of neurology.

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

L. Kappos, C. Polman, M. Hutchinson, 2016, Multiple sclerosis.

P300 analysis techniques in cognitive impairment after brain injury: Comparison with neuropsychological and imaging data

N. Maurits, J. De Keyser, J. van der Naalt, 2008, Brain injury.

Single MRI‐Based Volumetric Assessment in Clinical Practice Is Associated With MS‐Related Disability

G. Nagels, M. Cambron, J. De Keyser, 2018, Journal of magnetic resonance imaging : JMRI.

Plasma homocysteine levels in multiple sclerosis

J. De Keyser, M. Koch, A. Teelken, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions

K. Kersse, P. Vandenabeele, J. De Keyser, 2014, Cell death & disease.

Opposite effects of one session of 1 Hz rTMS on functional connectivity between pre-supplementary motor area and putamen depending on the dyskinesia state in Parkinson's disease

Guo-Rong Wu, J. de Mey, C. Baeken, 2021, Clinical Neurophysiology.

Predictive value of clinical characteristics for ‘benign’ multiple sclerosis

J. De Keyser, G. Ramsaransing, 2007, European journal of neurology.

Cerebral white matter blood flow and energy metabolism in multiple sclerosis

J. Hoogduin, M. Cambron, J. De Keyser, 2013, Multiple sclerosis.

Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.

N. Wilczak, J. De Keyser, E. Zeinstra, 2004, Trends in pharmacological sciences.

Perceived neuropsychological impairment inversely related to self‐reported health and employment in multiple sclerosis

R. Benedict, G. Nagels, J. De Keyser, 2019, European journal of neurology.

Worsening of symptoms of multiple sclerosis associated with carbamazepine

J. De Keyser, G. Ramsaransing, C. Zwanikken, 2000, BMJ : British Medical Journal.

Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis

J. De Keyser, M. D'hooghe, 2012, Expert review of neurotherapeutics.

Timing of birth and disease progression in multiple sclerosis

J. De Keyser, H. Tremlett, M. Koch, 2008, Multiple sclerosis.

Progression in familial and nonfamilial MS

J. De Keyser, M. Heerings, J. Mostert, 2008, Multiple sclerosis.

β2-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations

J. Aerts, J. De Keyser, G. Laureys, 2014, Journal of Neuroinflammation.

Absence of system xc− on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis

J. De Keyser, P. Maher, P. Albrecht, 2017, Journal of Neuroinflammation.

Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection

G. Nagels, J. De Keyser, J. Van Schependom, 2014, NeuroImage: Clinical.

Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis

N. Wilczak, J. De Keyser, D. Chesik, 2005, Multiple sclerosis.

Treatment of seizures in multiple sclerosis.

J. De Keyser, M. Koch, M. Uyttenboogaart, 2009, The Cochrane database of systematic reviews.

Bromocriptine therapy in multiple sclerosis: an open label pilot study.

J. De Keyser, T. Buisseret, G. Ebinger, 1994, Clinical neuropharmacology.

Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta‐analysis

J. De Keyser, K. Wynia, B. Middel, 2005, Acta neurologica Scandinavica.

JAK2‐V617F mutation in cerebral venous thrombosis

J. van der Meer, J. De Keyser, K. Koopman, 2009, Journal of thrombosis and haemostasis : JTH.

Central IGF‐I Receptors in the Brain are Instrumental to Neuroprotection by Systemically Injected IGF‐I in a Rat Model for Ischemic Stroke

J. De Keyser, A. De Smedt, R. Kooijman, 2016, CNS neuroscience & therapeutics.

Stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP)

H. de Ruiter, J. De Keyser, K. Wynia, 2008, Disability and rehabilitation.

Guillain‐Barré syndrome as the presenting manifestation of hepatitis C infection

J. De Keyser, G. Ebinger, M. Hautekeete, 1993, Neurology.

Utility of the stroke-thrombolytic predictive instrument

J. De Keyser, G. Luijckx, P. Vroomen, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

tPA treatment for acute ischaemic stroke in patients with leukoaraiosis

J. De Keyser, G. Luijckx, P. Vroomen, 2010, European journal of neurology.

AMPA Antagonist ZK200775 in Patients With Acute Ischemic Stroke: Possible Glial Cell Toxicity Detected by Monitoring of S-100B Serum Levels

M. Versavel, H. Diener, M. Hommel, 2002, Stroke.

Astrocytic beta2-adrenergic receptors and multiple sclerosis.

N. Wilczak, J. De Keyser, E. Zeinstra, 2004, Neurobiology of disease.

Reducing discrepancies between MS patients' needs and use of healthcare services by applying a transmural care model.

J. De Keyser, D. Jansen, B. Oeseburg, 2004, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

Reply to the Letter by van Breda et al.: Reduction of Body Temperature with Paracetamol in Patients with Acute Stroke: Randomized Clinical Trials Are Needed

J. De Keyser, G. Sulter, 2004, Cerebrovascular Diseases.

RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions

K. Kersse, P. Vandenabeele, J. De Keyser, 2014, Cell Death and Disease.

Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.

J. De Keyser, M. D'hooghe, 2012, Expert review of neurotherapeutics.

University of Groningen Development and testing psychometric properties of an ICF-based health measure Bos, Isaac; Kuks, Jan B. M.; Wynia, Klaske

H. de Ruiter, J. De Keyser, K. Wynia, 2018 .

Sudden hearing loss and facial palsy at the contralateral side following acoustic tumour removal.

J. De Keyser, G. Ebinger, M. Bruyland, 1983, Journal of neurology, neurosurgery, and psychiatry.

A Wernicke's encephalopathy‐like neurotoxicity induced by erbulozole

J. De Keyser, J. De Grève, S. Van Belle, 1991, Neurology.

Involvement of morbilliviruses in the pathogenesis of demyelinating disease

N. Wilczak, J. De Keyser, D. Chesik, 2022 .

Bromide intoxication due to chronic intake of a bromide containing antacid.

J. De Keyser, D. Deleu, G. Ebinger, 1985, Acta gastro-enterologica Belgica.

Prehospital Unassisted Assessment of Stroke Severity Using Telemedicine: A Feasibility Study

Ives Hubloue, Melissa Cambron, M. Cambron, 2013, Stroke.

Unassisted Assessment of Stroke Severity Using Telemedicine

Peter Mariën, Philippe Paquier, P. Paquier, 2013, Stroke.

Response to Grech et al.: FLOUX-PMS study sample considerations

J. De Keyser, J. Mostert, 2019, Multiple Sclerosis.

Variations of blood pressure in stroke unit patients may result from alternating body positions.

M. Aries, B. Kremer, J. De Keyser, 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Loss of high‐affinity agonist receptor binding in Alzheimer's disease

J. De Keyser, 1992, Annals of neurology.

Cerebral blood flow velocity changes during upright positioning in bed after acute stroke: an observational study

M. Aries, B. Kremer, J. De Keyser, 2013, BMJ Open.

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis

J. De Keyser, J. Keyser, M. Koch, 2006, Journal of Neurology.

Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide

Y. Michotte, J. De Keyser, R. Kooijman, 2012, Journal of Neuroinflammation.

Unassisted Assessment of Stroke Severity Using Telemedicine

P. Paquier, P. Mariën, J. De Keyser, 2013, Stroke.

Adding a subjective dimension to an ICF-based disability measure for people with multiple sclerosis: development and use of a measure for perception of disabilities

H. de Ruiter, J. De Keyser, K. Wynia, 2009, Disability and rehabilitation.

The impact of disabilities on quality of life in people with multiple sclerosis

J. De Keyser, K. Wynia, S. Reijneveld, 2008, Multiple sclerosis.

Tremor in multiple sclerosis

J. De Keyser, J. Mostert, M. Koch, 2007, Journal of Neurology.

Development and Pilot Testing of 24/7 In-Ambulance Telemedicine for Acute Stroke: Prehospital Stroke Study at the Universitair Ziekenhuis Brussel-Project

A. Dupont, K. Putman, J. De Keyser, 2016, Cerebrovascular Diseases.

The European Stroke Organisation Guidelines: a standard operating procedure

H. Diener, D. Leys, J. Ferro, 2015, International journal of stroke : official journal of the International Stroke Society.

Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis

J. De Keyser, M. D’haeseleer, R. Kooijman, 2020, Frontiers in Pharmacology.

Central IGF‐I Receptors in the Brain are Instrumental to Neuroprotection by Systemically Injected IGF‐I in a Rat Model for Ischemic Stroke

J. De Keyser, A. De Smedt, R. Kooijman, 2016, CNS neuroscience & therapeutics.

Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke.

J. De Keyser, R. Woestenborghs, A. van Peer, 1997, Clinical therapeutics.

Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis

J. De Keyser, M. D'hooghe, 2012, Expert review of neurotherapeutics.

Prehospital Unassisted Assessment of Stroke Severity Using Telemedicine: A Feasibility Study

M. Cambron, J. De Keyser, M. Moens, 2013, Stroke.

Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis

J. De Keyser, J. Keyser, M. Koch, 2006, Journal of the Neurological Sciences.